Nextbiotics is a biotechnology and synthetic biology company headquartered in San Francisco, California that was founded in 2017 with the goal of leveraging cutting edge synthetic biology tools and bacteriophage technology to provide unique solutions to the antibiotic resistance crisis.
The company combines bacteriophage therapy (Phage therapy) with CRISPR technology to reverse antibiotic resistance. The engineered viruses will specifically target drug-resistant bacteria and generate double-strand breaks, destroying the drug resistant genes or the genomic DNA of the bacteria, which will kill the bacteria.
Company Details
- Employees
- 59
- Founded
- -
- Address
- 2945 Webster St, Oakland,california 94609,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- southernurologyla.com
- Keywords
- San Francisco.
- HQ
- Oakland, California
Nextbiotics Inc Questions
Nextbiotics Inc's website is southernurologyla.com
Nextbiotics Inc's LinkedIn profile is https://www.linkedin.com/company/nextbiotics-inc
Nextbiotics Inc has
59 employees.
View email and phone details for 59
employees at Nextbiotics Inc.
Nextbiotics Inc's industry is
Biotechnology Research
Nextbiotics Inc's top competitors are
Sensei,
Aumed,
Ginkgo Bioworks, Inc.,
Aziya Immunopreparat,
Compound Foods,
Microgen Healthcare Pvt Ltd,
Intodeworld, Inc.,
Phagelux Agrihealth Inc.,
Eligo Bioscience,
Circularis Biotechnologies.
Nextbiotics Inc's categories are Biotechnology Research
Nextbiotics Inc's founding year is 2017
